Digital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Our content is fact checked by our senior editorial staff to reflect accuracy and ensure our readers get sound information and advice to make the smartest, healthiest choices.
During the questionnaire, participants were asked about the number of hours they spent on their phones and where they kept their devices when not in use. In total, 2,759 men answered the question about mobile phone use, and 2,764 gave details about where they kept their phone, allowing researchers to draw connections between these two factors and sperm count.were"significantly higher in the group of men who did not use their phones more than once per week.
Men who used their phones more often were also found to weigh more and have a higher body mass index , and more of these participants reported smoking cigarettes and drinking alcohol.Given how integral cell phones are to our daily lives, this data may be disconcerting. However, the news isn't all bad—according to the study results, keeping a mobile phone in one's pants pocket wasn't associated with lower sperm counts.
Researchers wrote that this is"in line with the transition to new technologies, mainly from 2G to 3G to 4G, and the corresponding decrease in the phone's output power."when using energy to send and receive signals, and this energy is what researchers have posited is connected to sperm quality. However, newer networks require less power to transmit signals, meaning it could also have less of an effect on sperm.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA panel weighs CRISPR-based sickle cell therapyThe FDA must decide whether to approve the therapy by Dec. 8.
Read more »
Crispr Therapeutics’ stock soars premarket after positive meeting of FDA panel on sickle-cell disease therapyCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »
FDA advisers see no roadblocks for gene-editing treatment for sickle cell diseaseAdvisers to the Food and Drug Administration meeting Tuesday paved the way for the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline.
Read more »
FDA moves closer to sickle cell cure that uses gene editingBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Potential cure for sickle cell disease raises few concerns for FDA panelVertex Pharmaceuticals has hailed its treatment as 'transformative' for patients with sickle cell disease. The FDA will decide on approval soon.
Read more »
CATL’s New Factory Can Produce One Cell Per Second, Battery Pack In 2.5 MinutesCATL claims to have achieved a blistering battery production rate of one cell per second and an entire pack in 2.5 minutes.
Read more »